Cancer survivorship issues for minority and underserved populationsGILLIGAN, Timothy D; CARRINGTON, Marilyn A; SELLERS, Thomas P et al.Cancer epidemiology, biomarkers & prevention. 2003, Vol 12, Num 3, pp 284s-286s, issn 1055-9965Conference Paper

Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migrationWOOD, Hadley M; REUTHER, Alwyn M; GILLIGAN, Timothy D et al.The Journal of urology. 2007, Vol 178, Num 4, pp 1271-1276, issn 0022-5347, 6 p., 1Article

Impact of race on survival in men with metastatic hormone-refractory prostate cancerHALABI, Susan; SMALL, Eric J; VOGELZANG, Nicholas J et al.Urology (Ridgewood, NJ). 2004, Vol 64, Num 2, pp 212-217, issn 0090-4295, 6 p.Article

Cessation of Vascular Endothelial Growth Factor―Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma: Feasibility and Clinical OutcomeSADEGHI, Sarmad; ALBIGES, Laurence; WOOD, Laura S et al.Cancer. 2012, Vol 118, Num 13, pp 3277-3282, issn 0008-543X, 6 p.Article

Intertubular growth in pure seminomas : associations with poor prognostic parametersBROWNE, Tara-Jane; RICHIE, Jerome P; GILLIGAN, Timothy D et al.Human pathology. 2005, Vol 36, Num 6, pp 640-645, issn 0046-8177, 6 p.Article

African-American men's perceptions about prostate cancer : Implications for designing educational interventionsALLEN, Jennifer D; KENNEDY, Mark; WILSON-GLOVER, Athene et al.Social science & medicine (1982). 2007, Vol 64, Num 11, pp 2189-2200, issn 0277-9536, 12 p.Article

American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell TumorsGILLIGAN, Timothy D; SEIDENFELD, Jerome; BASCH, Ethan M et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3388-3404, issn 0732-183X, 17 p.Article

Defining the Optimal Treatment for Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer Using Decision AnalysisNGUYEN, Carvell T; FU, Alex Z; GILLIGAN, Timothy D et al.Journal of clinical oncology. 2010, Vol 28, Num 1, pp 119-125, issn 0732-183X, 7 p.Article

A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancerOH, William K; HAGMANN, Elizabeth; MANOLA, Judith et al.Clinical cancer research. 2005, Vol 11, Num 1, pp 284-289, issn 1078-0432, 6 p.Article

Management of Low-stage Nonseminomatous Germ Cell Tumors of Testis: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009STEPHENSON, Andrew J; APRIKIAN, Armen G; GILLIGAN, Timothy D et al.Urology (Ridgewood, NJ). 2011, Vol 78, Num 4A, issn 0090-4295, S444-S455, SUPArticle

Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapyGRIBBEN, John G; RYAN, David P; RICHARDSON, Paul G et al.Clinical cancer research. 2005, Vol 11, Num 12, pp 4430-4436, issn 1078-0432, 7 p.Article